دورية أكاديمية

Effectiveness of a red cell antigen-matching transfusion protocol in sickle cell disease patients.

التفاصيل البيبلوغرافية
العنوان: Effectiveness of a red cell antigen-matching transfusion protocol in sickle cell disease patients.
المؤلفون: Dezan, M. R., Oliveira, V. B., Bianchi, J. V. S., Rodrigues, V., Solano, J. H., Gomes, F. C., Bonifácio, S. L., Levi, J. E., Guallandro, S. F. M., Krieger, J. E., Pereira, A. C., Sabino, E. C., Mendrone‐Júnior, A., Dinardo, C. L.
المصدر: ISBT Science Series; Dec2016, Vol. 11 Issue 3, p132-139, 8p
مصطلحات موضوعية: SICKLE cell anemia treatment, ANEMIA, RED blood cell transfusion, BLOOD transfusion, IMMUNOGLOBULINS, PATIENTS
مستخلص: Background and objectives To date, it is unclear whether antigen matching is effective in reducing antibody development and whether transfusing blood from non-Caucasian donors reduces alloimmunization in sickle cell disease patients ( SCP). This study was designed to evaluate the effectiveness of an antigen-matching strategy supplied by a mixed donor population, in reducing alloimmunization in SCPs. Methods Eighty SCPs transfused with C-, E- and K-matched units and 2000 donors were genotyped for the most relevant RBC antigens, and resulting genotypic frequencies were compared. Also, alloantibodies specificity and clinical complications were evaluated in SCPs. Results A high alloimmunization rate was observed despite the prophylaxis protocol (62·1%). The main cause underlying lack of effectiveness was transfusion of non-matched units in external hospitals. Even though our donor population was ethnically mixed, it still exhibited antigenic differences in relation to SCPs (C and Fya). Frequency of clinical complications was similar between alloimmunized and non-alloimmunized patients. Conclusions Prospective antigen matching is an unattractive alloimmunization prophylaxis for SCPs if not associated with strategies to minimize the hazards related to transfusions at non-index hospitals. Even in a highly mixed donor population, antigenic discrepancies in SCPs are high, increasing the risk of antibody development. [ABSTRACT FROM AUTHOR]
Copyright of ISBT Science Series is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17512816
DOI:10.1111/voxs.12281